microdosing glp-1 agonists THE PROGRAM Why Are Fit Guys Microdosing
Description
The real problem seems to be retention
Always follow your providers guidance and reach out with any questions or concerns
Various GLP-1RAs have been demonstrated to have significant benefits in in vitro and in vivo models of neurodegenerative diseases through modulating a variety of pathogenic mechanisms, including neuroinflammation, autophagy, mitochondrial dysfunction, and the abnormal phosphorylation of pathognomonic proteins
Read highlights from the released 2025 Standards of Care, including recommendations for CGM use in type 2 diabetes for the first time, the use of GLP-1 drugs for kidney and heart benefits and a warning of DKA risk in recreational marijuana use.
Get Guidance from Set Point.
